Comparison of the ISIs that caused 0%, 50% and 100% decreases in response magnitudes (AI spikes, AI fEPSP and MGBv spikes) to succeeding tone. by Colin Xiong (9182695)

SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

“…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”

DCD is strikingly decreased in HS lesions. by Margaret Coates (6058580)

“…Non-lesional and lesional samples were compared using a paired t-test. …”

LSPC treatment decreases neuropathology in prion-infected mice. by Heather Bender (363996)

“…<p>Immunohistochemistry (IHC) of brain sections through the (A) cerebellum and (B) hippocampus in infected and uninfected mice reveal that (A) while we observed no difference in cerebellar PrP^Res accumulation among infected untreated, non-responder or responder mice, both GFAP stain intensity, a measure of astrogliosis, and vacuolation, a hallmark of prion-mediated neurodegeneration, were significantly decreased in LSPC responder mice. …”

Viral replication in obese mice results in decreased genetic diversity. by James Weger-Lucarelli (603766)

AIM-100 reduces dsRNA silencing in body wall muscle and decreases DA neurodegeneration. by Anthony L. Gaeta (13272609)

Mitigation (decreasing) scenario. by Fabio Correddu (12501799)

Crosslinking decreases the alignment of fibers associated with individual cells migrating out of spheroids. by Michael Pamonag (12295175)

AMPs are increased in lesional HS, but DCD and other sweat-gland associated proteins are decreased. by Margaret Coates (6058580)

“…<p>(A) Volcano plot showing increased or decreased genes in HS. …”

The synchronous activity of SGN fiber populations is disrupted and their response to sound is decreased with increasing levels of <i>L</i>_<i>u</i> heterogeneity. by Maral Budak (6680351)

The gut microbiome and metabolome in kidney transplant recipients with normal and moderately decreased kidney function by Yang Lan (1750390)

For each level of risk, we plot the proportion of respondents willing to seek vaccination across ages. by Bert Baumgaertner (3595814)

Image_4_GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma.tif by Yu-an Qiu (10272836)

“…In the present study, we found a remarkable difference in GPER staining between tumor tissue (100/141, 70.9%) and matched non-tumor tissue (27/30, 90.0%). …”

Image_3_GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma.tif by Yu-an Qiu (10272836)

“…In the present study, we found a remarkable difference in GPER staining between tumor tissue (100/141, 70.9%) and matched non-tumor tissue (27/30, 90.0%). …”

Image_2_GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma.tif by Yu-an Qiu (10272836)

“…In the present study, we found a remarkable difference in GPER staining between tumor tissue (100/141, 70.9%) and matched non-tumor tissue (27/30, 90.0%). …”

Image_1_GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma.tif by Yu-an Qiu (10272836)

“…In the present study, we found a remarkable difference in GPER staining between tumor tissue (100/141, 70.9%) and matched non-tumor tissue (27/30, 90.0%). …”

Rcan2-mediated decrease in intracellular K⁺ involves Kcnk5b. by Xiaowen Jiang (8291814)

Observational study on Swedish plaque psoriasis patients receiving narrowband-UVB treatment show decreased S100A8/A9 protein and gene expression levels in lesional psoriasis skin but no effect on S100A8/A9 protein levels in serum by Albert Duvetorp (6454001)

Taurine Chloramine decreases cell viability and cytokine production in blood and spleen lymphocytes from septic rats by DHÉBORA M. DALL’IGNA (10365522)

“…TauCl decreased lymphocyte viability and altered the secretion pattern of important inflammatory mediators in non-specific-phenotype manner. …”

DataSheet_1_GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma.docx by Yu-an Qiu (10272836)

“…In the present study, we found a remarkable difference in GPER staining between tumor tissue (100/141, 70.9%) and matched non-tumor tissue (27/30, 90.0%). …”